{"id":"W3010847380","doi":"10.1016/j.msard.2019.11.078","title":"Efficacy and Safety of the Bruton's Tyrosine Kinase Inhibitor Evobrutinib in Patients with Relapsing Multiple Sclerosis Over 48 Weeks: A Randomized, Placebo-Controlled, Phase 2 Study","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"NeuroRx Research (Canada); University of Toronto; Montreal Neurological Institute and Hospital","funders":"","keywords":"Medicine; Placebo; Clinical endpoint; Gastroenterology; Internal medicine; Randomized controlled trial; Confidence interval; Adverse effect; Dimethyl fumarate; Multiple sclerosis; Immunology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008715885,0.0004757665,0.001525835,0.0001977508,0.0002951146,0.00005647123,0.0001870367,0.0002571955,0.00006461778],"category_scores_gemma":[0.002659324,0.0002893405,0.0002446268,0.0008802587,0.0007819873,0.000179875,0.0002853878,0.00066478,0.000004395591],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006493245,"about_ca_system_score_gemma":0.000525367,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001144704,"about_ca_topic_score_gemma":0.0002087946,"domain_scores_codex":[0.9961032,0.0005772238,0.00112406,0.0008023738,0.0008245057,0.0005686831],"domain_scores_gemma":[0.9973513,0.001274956,0.0003868013,0.0004896971,0.0001418484,0.0003554136],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8145726,0.004965288,0.1607121,0.0002118968,0.0009509258,0.000009784542,0.006629384,0.0005175031,0.001950377,0.000008481808,0.0001630336,0.009308636],"study_design_scores_gemma":[0.8359392,0.001121991,0.1255831,0.001115442,0.0005004905,0.000001675993,0.0009149153,0.03429853,0.0001909002,0.000003408628,0.00003874304,0.0002915554],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9883627,0.001629367,0.00001738745,0.0008483389,0.0001403924,0.008773709,0.00004080939,0.00006002787,0.000127227],"genre_scores_gemma":[0.998642,0.0007689517,0.00008507339,0.0001393864,0.00003076501,0.0001655086,0.00003115374,0.00008072915,0.00005643251],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03512903,"threshold_uncertainty_score":0.9999559,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01705043165020081,"score_gpt":0.2431664878634373,"score_spread":0.2261160562132365,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}